%% Created using Papers on Mon, 24 Mar 2014.
%% http://papersapp.com/papers/

@article{Slingluff:2013ej,
author = {Slingluff, Craig L and Petroni, Gina R and Molhoek, Kerrington R and Brautigan, David L and Chianese-Bullock, Kimberly A and Shada, Amber L and Smolkin, Mark E and Olson, Walter C and Gaucher, Alison and Chase, Cheryl Murphy and Grosh, William W and Weiss, Geoffrey R and Wagenseller, Aubrey G and Olszanski, Anthony J and Martin, Lainie and Shea, Sofia M and Erdag, Gulsun and Ram, Prahlad and Gershenwald, Jeffrey E and Weber, Michael J},
title = {{Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).}},
journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
year = {2013},
volume = {19},
number = {13},
pages = {3611--3620},
month = jul
}

@article{Wagenseller:2013fj,
author = {Wagenseller, Aubrey G and Shada, Amber and D'Auria, Kevin M and Murphy, Cheryl and Sun, Dandan and Molhoek, Kerrington R and Papin, Jason A and Dutta, Anindya and Slingluff, Craig L},
title = {{MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab.}},
journal = {Journal of translational medicine},
year = {2013},
volume = {11},
number = {1},
pages = {218}
}

@article{Schuster:2012fo,
author = {Schuster, Cornelia and Eikesdal, Hans P and Puntervoll, Hanne and Geisler, Jurgen and Geisler, Stephanie and Heinrich, Daniel and Molven, Anders and Lonning, Per E and Akslen, Lars A and Straume, Oddbjorn},
title = {{Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension}},
journal = {PLoS ONE},
year = {2012},
volume = {7},
number = {6},
pages = {e38364},
month = jun
}

@article{Ko:2011dk,
author = {Ko, Justin M and Fisher, David E},
title = {{A new era: melanoma genetics and therapeutics}},
journal = {The Journal of pathology},
year = {2011},
volume = {223},
number = {2},
pages = {242--251}
}

@article{Robert:2011vp,
author = {Robert, C and Thomas, L and Bondarenko, I},
title = {{Ipilimumab plus dacarbazine for previously untreated metastatic melanoma}},
journal = {{\ldots} England Journal of {\ldots}},
year = {2011}
}

@article{Hodi:2010wt,
author = {Hodi, F S and O'Day, S J and McDermott, D F},
title = {{Improved survival with ipilimumab in patients with metastatic melanoma}},
journal = {{\ldots} England Journal of {\ldots}},
year = {2010}
}

@article{Molhoek:2008jx,
author = {Molhoek, Kerrington R and Griesemann, Heinrich and Shu, Jianfen and Gershenwald, Jeffrey E and Brautigan, David L and Slingluff, Craig L},
title = {{Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.}},
journal = {Cancer research},
year = {2008},
volume = {68},
number = {11},
pages = {4392--4397},
month = jun
}

@article{Varker:2007dj,
author = {Varker, Kimberly A and Biber, Jennifer E and Kefauver, Cheryl and Jensen, Rhonda and Lehman, Amy and Young, Donn and Wu, Haifeng and Lesinski, Gregory B and Kendra, Kari and Chen, Helen X and Walker, Michael J and Carson III, William E},
title = {{A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma}},
journal = {Annals of Surgical Oncology},
year = {2007},
volume = {14},
number = {8},
pages = {2367--2376}
}

@article{Margolin:2004vl,
author = {Margolin, K A and Longmate, J and Baratta, T and Synold, T},
title = {{CCI-779 in metastatic melanoma: A phase II trial of the California Cancer Consortium}},
journal = {J Clin {\ldots}},
year = {2004}
}

